Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease

Experimental Hematology

Volumn 27, Issue 5, 1999, Pages 868-874

  Peters, Anke M J ^a   Kohfink, Barbara ^b   Martin, Heike ^c   Griesinger, Frank ^c   Wörmann, Bernhard ^c   Gahr, Manfred ^a   Roesler, Joachim ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Apoptosis; Canale Smith syndrome; CD95; Lymphoproliferative syndrome

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CHILD; CLINICAL ARTICLE; FAMILIAL DISEASE; FEMALE; HEMOLYSIS; HETEROZYGOSITY; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SPLENOMEGALY; T CELL LYMPHOMA;

ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; BASE SEQUENCE; CHILD, PRESCHOOL; DNA PRIMERS; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, T-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; PEDIGREE; POINT MUTATION;

EID: 0032930197     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00033-8     Document Type: Article

References (30)

1. Krammer P.H., Behrmann I., Daniel P., Dhein J., Debatin K.M. Regulation of apoptosis in the immune system. Curr Opin Immunol. 6:1994;279.
2. Dhein J., Walczak H., Baeumler C., Debatin K.M., Krammer P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:1995;438.
3. Brunner T., Mogil R.J., LaFace D., Yoo N.J., Mahboubi A., Echeverri F., Martin S.J., Force W.R., Lynch D., Ware C.F., Green D.R. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:1995;441.
4. Ju S.T., Panka D.J., Cui H., Ettinger R., El-Khatib M., Sherr D.H., Stanger B.Z., Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:1995;444.
5. Trauth B.C., Klas C., Peters A.M.J., Matzku S., Möller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:1989;301.
6. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 169:1989;1747.
7. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.I., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233.
8. Oehm A., Behrmann I., Falk W., Pawlita W., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B.C., Ponstingl H., Krammer P.H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem. 267:1992;10709.
9. Itoh N., Nagata S. A novel protein domain required for apoptosis. J Biol Chem. 268:1993;10937.
10. Tartaglia L.A., Ayres M.T., Wong G.H., Goeddel D.V. A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74:1993;845.
11. Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:1992;314.
12. Takahashi T., Tanaka M., Brannan C.I., Jenkins N.A., Copeland N.G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:1994;969.
13. Canale V.C., Smith C.H. Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr. 70:1967;891.
14. Sneller M.C., Straus S.E., Jaffe E.S., Jaffe J.S., Fleisher T.A., Stetler-Stevenson M., Strober W. A novel lymphoproliferative autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest. 90:1992;334.
15. Rieux-Laucat F., LeDeist F., Hivroz C., Roberts A.G., Debatin K.M., Fischer A., de Villartay J.P. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 268:1995;1347.
16. Fisher G.H., Rosenberg F.J., Straus S.E., Dale J.K., Middleton L.A., Lin A.Y., Strober W., Lenardo M.J., Puck J.M. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 81:1995;935.
17. Straus S.E., Lenardo M.J., Puck J.M. The Canale-Smith-Syndrome. N Engl J Med. 336:1997;1457.
18. Koester S.K., Roth P., Mikulka W.R., Schlossmann S.F., Zang C., Bolton W.E. Monitoring of early cellular responses in apoptosis is aided by the mitochondrial membrane protein-specific monoclonal antibody APO2.7. Cytometry. 29:1997;306.
19. Fiucci G., Ruberti G. Detection of polymorphisms within the FAS cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics. 39:1994;437.
20. Dianzani U., Bragardo M., DiFranco D., Alliaudi C., Scagni P., Buonfiglio D., Redoglia V., Bonissoni S., Correra A., Dianzani I., Ramenghi U. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood. 89:1997;2871.
21. Sellner M.C., Wing J., Dale J.K., Strober W., Middelton L.A., Choi Y., Fleischer T.A., Lin M.S., Jaffe E.S., Puck J.M., Lenardo M.J., Straus S.E. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrom associated with abnormal lymphocyte apoptosis. Blood. 89:1997;1341.
22. O'Rourke A.M.K., Tewari M., Dixi U.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505.
23. Boldin M.P., Varfolomeev E., Pancer C., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/Apo1 contains a sequence motif related to the death domain. J Biol Chem. 270:1995;7995.
24. Huang B., Eberstadt M., Olejniczak E.T., Meadows R.D., Fesik S.W. NMR structure and mutagenesis of the Fas(Apo1/CD95) death domain. Nature. 384:1996;638.
25. Lin A., Dale J., Fleisher T., Fisher G., Rosenberg F., Lenardo M., Puck J., Middelton L., Corden B., Tucker M., Straus S. Familial aggregation of Hodgkin's disease (HD), autoimmune lymphoproliferative syndrom (ALPS) and germline Fas mutations. Blood. 86(suppl. 1):1995;271a. (abstr).
26. Landowski T.H., Qu N., Buyuksal I., Painter J.S., Dalton W.S. Mutations in the Fas antigen in patients with multiple myeloma. Blood. 90:1997;4266.
27. Nagata S. Apoptosis by death factor. Cell. 88:1997;355.
28. Carlsten H., Toukowski A., Jonsson R., Nilsson L.A. Expression of heterozygous lpr gene in MRL Mice. Scand J Immunol. 32:1990;21.
29. Muzio M., Chinnaiyan A.M., Kischkel F.C., O'Rourke K., Shevchenko A., Ni J., Scaffidi C., Bretz J.D., Zhang M., Gentz R., Mann M., Krammer P.H.et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo1) death-inducing signaling complex. Cell. 85:1996;817.
30. Zhang J., Cado D., Chen A., Kabra N., Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort/1. Nature. 392:1998;296.